Secondly, evidence of the PLGF or sFlt‐1/PLGF ratio published to date makes it highly likely that the decision when to deliver women with gestational hypertension or early disease of pre‐eclampsia after 34+0 weeks of gestation can be refined when these markers are added to clinical decision‐making. Here, PGF is linked to preeclampsia.